| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 4 |
| NetGPI | no | yes: 0, no: 4 |
Related structures:
AlphaFold database: Q4QB56
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 150 | 154 | PF00656 | 0.610 |
| CLV_NRD_NRD_1 | 35 | 37 | PF00675 | 0.687 |
| DOC_USP7_MATH_1 | 13 | 17 | PF00917 | 0.605 |
| DOC_USP7_MATH_1 | 32 | 36 | PF00917 | 0.694 |
| DOC_USP7_UBL2_3 | 15 | 19 | PF12436 | 0.585 |
| DOC_USP7_UBL2_3 | 7 | 11 | PF12436 | 0.650 |
| DOC_WW_Pin1_4 | 51 | 56 | PF00397 | 0.572 |
| MOD_CK1_1 | 3 | 9 | PF00069 | 0.594 |
| MOD_CK1_1 | 35 | 41 | PF00069 | 0.617 |
| MOD_CK2_1 | 19 | 25 | PF00069 | 0.575 |
| MOD_CK2_1 | 6 | 12 | PF00069 | 0.629 |
| MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.587 |
| MOD_GlcNHglycan | 32 | 35 | PF01048 | 0.691 |
| MOD_GlcNHglycan | 37 | 40 | PF01048 | 0.746 |
| MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.649 |
| MOD_GSK3_1 | 19 | 26 | PF00069 | 0.700 |
| MOD_N-GLC_1 | 23 | 28 | PF02516 | 0.585 |
| MOD_N-GLC_1 | 30 | 35 | PF02516 | 0.603 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.596 |
| MOD_NMyristoyl | 1 | 7 | PF02799 | 0.647 |
| MOD_PKA_2 | 35 | 41 | PF00069 | 0.721 |
| MOD_ProDKin_1 | 51 | 57 | PF00069 | 0.576 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A3Q8IFV6 | Leishmania donovani | 57% | 95% |
| A4I0F4 | Leishmania infantum | 61% | 72% |
| E9AWB7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 45% | 86% |